Display options
Share it on

Fluids Barriers CNS. 2013 Jan 10;10(1):2. doi: 10.1186/2045-8118-10-2.

Modeling the blood-brain barrier using stem cell sources.

Fluids and barriers of the CNS

Ethan S Lippmann, Abraham Al-Ahmad, Sean P Palecek, Eric V Shusta

Affiliations

  1. Dept, of Chemical and Biological Engineering, University of Wisconsin-Madison, 1415 Engineering Dr,, Madison, WI, 53706, USA. [email protected].

PMID: 23305164 PMCID: PMC3564868 DOI: 10.1186/2045-8118-10-2

Abstract

The blood-brain barrier (BBB) is a selective endothelial interface that controls trafficking between the bloodstream and brain interstitial space. During development, the BBB arises as a result of complex multicellular interactions between immature endothelial cells and neural progenitors, neurons, radial glia, and pericytes. As the brain develops, astrocytes and pericytes further contribute to BBB induction and maintenance of the BBB phenotype. Because BBB development, maintenance, and disease states are difficult and time-consuming to study in vivo, researchers often utilize in vitro models for simplified analyses and higher throughput. The in vitro format also provides a platform for screening brain-penetrating therapeutics. However, BBB models derived from adult tissue, especially human sources, have been hampered by limited cell availability and model fidelity. Furthermore, BBB endothelium is very difficult if not impossible to isolate from embryonic animal or human brain, restricting capabilities to model BBB development in vitro. In an effort to address some of these shortcomings, advances in stem cell research have recently been leveraged for improving our understanding of BBB development and function. Stem cells, which are defined by their capacity to expand by self-renewal, can be coaxed to form various somatic cell types and could in principle be very attractive for BBB modeling applications. In this review, we will describe how neural progenitor cells (NPCs), the in vitro precursors to neurons, astrocytes, and oligodendrocytes, can be used to study BBB induction. Next, we will detail how these same NPCs can be differentiated to more mature populations of neurons and astrocytes and profile their use in co-culture modeling of the adult BBB. Finally, we will describe our recent efforts in differentiating human pluripotent stem cells (hPSCs) to endothelial cells with robust BBB characteristics and detail how these cells could ultimately be used to study BBB development and maintenance, to model neurological disease, and to screen neuropharmaceuticals.

References

  1. J Neurosci. 1987 Oct;7(10):3293-9 - PubMed
  2. Cell. 1998 Nov 13;95(4):507-19 - PubMed
  3. Nat Biotechnol. 2010 Feb;28(2):161-6 - PubMed
  4. J Cell Biol. 2008 Nov 3;183(3):409-17 - PubMed
  5. Biochem Biophys Res Commun. 1995 Jun 26;211(3):719-26 - PubMed
  6. Genes Cells. 2005 Jun;10(6):595-604 - PubMed
  7. Proc Natl Acad Sci U S A. 2011 May 10;108(19):7838-43 - PubMed
  8. Brain Res Dev Brain Res. 1995 Jun 27;87(1):69-76 - PubMed
  9. Brain Res Dev Brain Res. 1996 Oct 23;96(1-2):229-40 - PubMed
  10. J Cereb Blood Flow Metab. 2009 Sep;29(9):1491-502 - PubMed
  11. Nature. 2009 Jan 15;457(7227):277-80 - PubMed
  12. Nat Protoc. 2011 Oct 13;6(11):1710-7 - PubMed
  13. Cell Mol Neurobiol. 2005 Feb;25(1):41-58 - PubMed
  14. Cell Stem Cell. 2012 Jun 14;10(6):771-785 - PubMed
  15. Endocrinology. 2008 Dec;149(12):6251-61 - PubMed
  16. J Neurochem. 2011 Nov;119(3):507-20 - PubMed
  17. Nature. 1987 Jan 15-21;325(6101):253-7 - PubMed
  18. FASEB J. 2005 Nov;19(13):1872-4 - PubMed
  19. Cell. 2006 Aug 25;126(4):663-76 - PubMed
  20. J Neurochem. 2004 Apr;89(2):503-13 - PubMed
  21. Epilepsia. 2007 Mar;48(3):505-16 - PubMed
  22. Nature. 2010 Nov 25;468(7323):557-61 - PubMed
  23. J Cell Physiol. 1996 Jun;167(3):451-60 - PubMed
  24. Biotechnol Prog. 2007 Jan-Feb;23(1):18-23 - PubMed
  25. Science. 1998 Nov 6;282(5391):1145-7 - PubMed
  26. Brain Res Dev Brain Res. 2004 Aug 18;152(1):25-38 - PubMed
  27. Neuroreport. 2000 Apr 7;11(5):1081-4 - PubMed
  28. Brain Res. 1997 Sep 12;768(1-2):10-8 - PubMed
  29. J Cell Biol. 1991 Dec;115(6):1725-35 - PubMed
  30. Brain Res. 2007 Jul 23;1159:67-76 - PubMed
  31. Int J Dev Biol. 2011;55(4-5):467-76 - PubMed
  32. Biochem Pharmacol. 2009 Mar 1;77(5):897-909 - PubMed
  33. Nat Rev Drug Discov. 2004 Aug;3(8):711-5 - PubMed
  34. Nature. 1981 Jul 9;292(5819):154-6 - PubMed
  35. Int J Cell Biol. 2012;2012:508294 - PubMed
  36. BMC Neurosci. 2011 May 11;12:40 - PubMed
  37. Nat Med. 2003 Jul;9(7):900-6 - PubMed
  38. Circulation. 2012 Jan 3;125(1):87-99 - PubMed
  39. J Neurochem. 2006 May;97(4):922-33 - PubMed
  40. J Neurochem. 1986 Jun;46(6):1732-42 - PubMed
  41. Neurochem Int. 2009 Mar-Apr;54(3-4):253-63 - PubMed
  42. Rev Diabet Stud. 2010 Summer;7(2):93-104 - PubMed
  43. Nat Neurosci. 2008 Apr;11(4):429-39 - PubMed
  44. Mol Pharm. 2010 Aug 2;7(4):1057-68 - PubMed
  45. Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2807-12 - PubMed
  46. Nat Biotechnol. 2009 Sep;27(9):851-7 - PubMed
  47. J Cell Physiol. 1994 Apr;159(1):101-13 - PubMed
  48. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):2074-7 - PubMed
  49. Science. 1996 Jul 12;273(5272):242-5 - PubMed
  50. Nature. 1989 Aug 10;340(6233):471-3 - PubMed
  51. Brain Res. 1987 Nov;433(1):155-9 - PubMed
  52. Lab Chip. 2012 Apr 24;12(10):1784-92 - PubMed
  53. Science. 2010 Nov 12;330(6006):985-9 - PubMed
  54. Nat Biotechnol. 2011 May 22;29(6):528-34 - PubMed
  55. J Cell Mol Med. 2003 Apr-Jun;7(2):165-70 - PubMed
  56. Toxicol Appl Pharmacol. 2011 Nov 15;257(1):74-83 - PubMed
  57. Nature. 2009 Sep 17;461(7262):402-6 - PubMed
  58. Curr Pharm Des. 2011;17(26):2755-61 - PubMed
  59. J Neurosci Res. 2006 Jun;83(8):1515-24 - PubMed
  60. Nat Rev Neurosci. 2011 Mar;12(3):169-82 - PubMed
  61. J Control Release. 2001 Sep 11;76(1-2):139-47 - PubMed
  62. Methods Mol Med. 2003;89:375-82 - PubMed
  63. Nat Methods. 2011 May;8(5):424-9 - PubMed
  64. Proc Natl Acad Sci U S A. 2009 Sep 29;106(39):16698-703 - PubMed
  65. Mol Ther. 2013 Jan;21(1):240-50 - PubMed
  66. Nat Biotechnol. 2001 Dec;19(12):1129-33 - PubMed
  67. Science. 2008 Nov 21;322(5905):1247-50 - PubMed
  68. Science. 2012 Jul 20;337(6092):358-62 - PubMed
  69. Proc Natl Acad Sci U S A. 2010 Mar 2;107(9):4335-40 - PubMed
  70. J Cereb Blood Flow Metab. 2008 Jan;28(1):135-48 - PubMed
  71. J Comp Neurol. 1997 Nov 3;387(4):537-46 - PubMed
  72. Biochem Biophys Res Commun. 1999 Jul 22;261(1):108-12 - PubMed
  73. J Neurochem. 2011 Apr;117(2):333-45 - PubMed
  74. Toxicol Sci. 2011 Sep;123(1):281-9 - PubMed
  75. J Neurochem. 2008 Dec;107(5):1358-68 - PubMed
  76. J Cell Physiol. 2009 Mar;218(3):612-22 - PubMed
  77. Pharm Res. 1998 Jul;15(7):993-1000 - PubMed
  78. Sci Transl Med. 2010 Nov 17;2(58):58ps53 - PubMed
  79. Neuron. 1993 Jul;11(1):173-89 - PubMed
  80. Brain Res. 2009 Oct 6;1292:14-24 - PubMed
  81. Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):641-6 - PubMed
  82. Br J Pharmacol. 2003 May;139(2):329-36 - PubMed
  83. Cell Mol Life Sci. 2010 Nov;67(22):3837-47 - PubMed
  84. Angiogenesis. 2007;10(1):35-45 - PubMed
  85. J Neurosci Res. 2006 Dec;84(8):1656-68 - PubMed
  86. Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6537-42 - PubMed
  87. Cell. 1990 Aug 10;62(3):435-45 - PubMed
  88. Science. 2004 May 28;304(5675):1338-40 - PubMed
  89. Nature. 2012 Jan 25;482(7384):216-20 - PubMed
  90. Brain Res. 2005 Mar 21;1038(2):208-15 - PubMed
  91. Nature. 2012 May 16;485(7399):512-6 - PubMed
  92. Stem Cells. 2009 Mar;27(3):559-67 - PubMed
  93. J Pharm Sci. 2012 Apr;101(4):1337-54 - PubMed
  94. Dev Biol. 1981 May;84(1):183-92 - PubMed
  95. Anat Rec. 1988 Jun;221(2):663-77 - PubMed
  96. Adv Drug Deliv Rev. 1999 Apr 5;36(2-3):165-178 - PubMed
  97. Cell Stem Cell. 2011 Jul 8;9(1):17-23 - PubMed
  98. J Cereb Blood Flow Metab. 2011 Feb;31(2):693-705 - PubMed
  99. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7634-8 - PubMed
  100. Cell Mol Neurobiol. 2010 Apr;30(3):483-91 - PubMed
  101. J Angiogenes Res. 2010 Jan 14;2:1 - PubMed
  102. Nat Biotechnol. 2012 Aug;30(8):783-91 - PubMed
  103. Cell. 2007 Nov 30;131(5):861-72 - PubMed
  104. J Neurochem. 2003 Jul;86(1):179-95 - PubMed
  105. Brain Res. 1982 Jun 3;241(1):49-55 - PubMed
  106. Circulation. 2010 Mar 9;121(9):1113-23 - PubMed
  107. Int J Biochem Cell Biol. 2011 Sep;43(9):1284-93 - PubMed
  108. Cell Stem Cell. 2012 Apr 6;10(4):465-72 - PubMed
  109. Nat Biotechnol. 2008 Mar;26(3):313-5 - PubMed
  110. Brain Res. 2013 Jul 12;1521:1-15 - PubMed
  111. J Neurochem. 1990 May;54(5):1798-801 - PubMed
  112. Nat Biotechnol. 2001 May;19(5):475-9 - PubMed
  113. Neurosci Lett. 1986 May 6;66(1):39-42 - PubMed
  114. Cell Stem Cell. 2012 Jul 6;11(1):100-9 - PubMed
  115. J Physiol. 1990 Oct;429:47-62 - PubMed
  116. Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5567-72 - PubMed
  117. Science. 2007 Jul 20;317(5836):381-4 - PubMed
  118. Biochem Biophys Res Commun. 2008 Jul 18;372(1):243-8 - PubMed
  119. Nature. 2010 Sep 16;467(7313):285-90 - PubMed
  120. Cell. 2010 Nov 12;143(4):527-39 - PubMed
  121. Nat Med. 2000 Mar;6(3):271-7 - PubMed
  122. Nat Rev Drug Discov. 2011 Nov 11;10(12):915-29 - PubMed
  123. J Physiol. 1995 Oct 15;488 ( Pt 2):439-48 - PubMed
  124. Nature. 2010 Nov 25;468(7323):562-6 - PubMed
  125. J Cell Physiol. 1997 Nov;173(2):206-10 - PubMed
  126. Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4391-6 - PubMed
  127. Science. 2011 Dec 23;334(6063):1727-31 - PubMed
  128. Toxicol In Vitro. 2008 Apr;22(3):799-811 - PubMed
  129. J Cell Mol Med. 2005 Apr-Jun;9(2):373-9 - PubMed
  130. Cell. 2008 May 2;133(3):510-22 - PubMed
  131. Cell Mol Neurobiol. 2000 Feb;20(1):57-76 - PubMed
  132. J Neurosci. 2001 Mar 1;21(5):1538-47 - PubMed
  133. J Cereb Blood Flow Metab. 2012 Jan;32(1):81-92 - PubMed
  134. Nat Biotechnol. 2010 Aug;28(8):848-55 - PubMed
  135. Nat Biotechnol. 2011 Jul 07;29(8):731-4 - PubMed
  136. Cell Stem Cell. 2008 Sep 11;3(3):279-88 - PubMed
  137. Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5759-64 - PubMed
  138. Science. 2007 Dec 21;318(5858):1917-20 - PubMed
  139. J Neurochem. 2007 Apr;101(2):555-65 - PubMed

Publication Types